Amidst huge spike in number of corona cases across the globe with figure crossing 7-million mark, scientists are working hard to develop vaccine to combat COVID-19. Some countries including Britain and the United States, have achieved notable progress while getting initial breakthrough on the vaccine front.
AstraZeneca, a British pharma giant has announced that it was “on track” to roll out up to two billion doses in September. The The vaccine which is under the human trials phase currently, is being developed in partnership with the Oxford University. The company hopes to have millions of doses ready in the next few months, The Indian Express report said.
“So far we’re still on track… we are starting to manufacture this vaccine right now, and we have to have it ready to be used by the time we have the results,” The report quoted Pascal Soriot, chief executive of AstraZeneca, as saying to BBC Radio.. “Our present assumption is that we will have the data by the end of the summer, by August, so in September we should know whether we have an effective vaccine or not,” he further said.
In the initial phase of testing, the vaccine was tested on healthy volunteers of age 18 to 55. In the coming phases, researchers are to test the vaccine candidate in 10,260 more people, and they will also expand the age to include children and older people.
Meanwhile, US also said that it had already produced two million vaccine doses that are “ready to go” if they “check out for safety”.
President Donald Trump has said that the country already has 2 million doses of coronavirus vaccine ready to be rolled out if they check out for safety. “We had a meeting on vaccines yesterday. We are doing incredibly well. We can have some very positive surprises. Tremendous progress is being made on vaccines. In fact, we are ready to go in terms of transportation and logistics. We have over two million ready to go if it checks out for safety,” he said recently in a news conference.
India too has pledged $15 million to vaccine alliance GAVI at the Global Vaccine Summit hosted by the UK. “Our support to Gavi is not only financial. India’s huge demand brings down the global price of vaccines,”Prime Minister Modi had said while addressing the summit.